Compare DSP Healthcare Fund vs Tata India Pharma & Healthcare Fund
Risk
Very High
Very High
Rating
3.0
3.0
Min SIP Amount
₹100
₹100
Expense Ratio
1.94
2.15
NAV
₹36.00
₹27.91
Fund Started
12 Nov 2018
04 Dec 2015
Fund Size
₹3033.42 Cr
₹1300.81 Cr
Exit Load
Exit load of 0.50% if redeemed within 1 month.
Exit load of 0.25% if redeemed within 30 days.
1 Year
-2.87%
-2.03%
3 Year
19.79%
20.63%
5 Year
13.22%
13.50%
Equity
98.05%
97.56%
Cash
1.95%
2.44%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 8.79% |
Ipca Laboratories Ltd. | 8.55% |
Cipla Ltd. | 8.06% |
Globus Medical Inc | 7.69% |
Laurus Labs Ltd. | 6.50% |
Illumina Inc. (USA) | 6.47% |
Sai Life Sciences Ltd. | 5.90% |
Gland Pharma Ltd. | 5.53% |
Apollo Hospitals Enterprise Ltd. | 5.02% |
Pfizer Ltd. | 3.35% |
Sun Pharmaceutical Industries Ltd. | 9.66% |
Max Healthcare Institute Ltd. | 6.78% |
Divi's Laboratories Ltd. | 5.94% |
Abbott India Ltd. | 5.60% |
Healthcare Global Enterprises Ltd. | 5.04% |
Apollo Hospitals Enterprise Ltd. | 5.00% |
Cipla Ltd. | 4.55% |
Rainbow Children's Medicare Ltd. | 3.83% |
Mankind Pharma Ltd. | 3.40% |
Bayer CropScience Ltd. | 3.33% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
Launch Date
12 Nov 2018
04 Dec 2015
